Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Said

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
American Journal of Cancer Research|November 14, 2013
Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomyKiran Gollapudi, Colette Galet, Tristan Grogan, et al.
The Journal of Urology|August 21, 2002
Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtypeAmnon Zisman, Debby H Chao, Allan J Pantuck, et al.
The American Journal of Surgical Pathology|July 16, 2014
Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphomaElizabeth A Morgan, German A Pihan, Jonathan W Said, et al.
The American Journal of Pathology|February 26, 2004
An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomasKatrina K Hoyer, Mabel Pang, Dorina Gui, et al.
The Journal of Urology|August 21, 2002
Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate?Amnon Zisman, Allan J Pantuck, Debby H Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinomaAmnon Zisman, Allan J Pantuck, Jeffery Wieder, et al.
Blood|September 4, 2004
Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosisHiroshi Kawabata, Robert E Fleming, Dorina Gui, et al.
The Prostate|August 6, 2010
Chemoprevention of prostate cancer with lycopene in the TRAMP modelRamdev Konijeti, Susanne Henning, Aune Moro, et al.
International Journal of Cancer|May 9, 2008
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinomaJean-Jacques Patard, Patricia Fergelot, Pierre I Karakiewicz, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 27, 2003
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BVSven de Vos, Utz Krug, Wolf-Karsten Hofmann, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
American Journal of Cancer Research|November 14, 2013
Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomyKiran Gollapudi, Colette Galet, Tristan Grogan, et al.
The Journal of Urology|August 21, 2002
Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtypeAmnon Zisman, Debby H Chao, Allan J Pantuck, et al.
The American Journal of Surgical Pathology|July 16, 2014
Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphomaElizabeth A Morgan, German A Pihan, Jonathan W Said, et al.
The American Journal of Pathology|February 26, 2004
An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomasKatrina K Hoyer, Mabel Pang, Dorina Gui, et al.
The Journal of Urology|August 21, 2002
Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate?Amnon Zisman, Allan J Pantuck, Debby H Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinomaAmnon Zisman, Allan J Pantuck, Jeffery Wieder, et al.
Blood|September 4, 2004
Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosisHiroshi Kawabata, Robert E Fleming, Dorina Gui, et al.
The Prostate|August 6, 2010
Chemoprevention of prostate cancer with lycopene in the TRAMP modelRamdev Konijeti, Susanne Henning, Aune Moro, et al.
International Journal of Cancer|May 9, 2008
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinomaJean-Jacques Patard, Patricia Fergelot, Pierre I Karakiewicz, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 27, 2003
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BVSven de Vos, Utz Krug, Wolf-Karsten Hofmann, et al.
Pageof 13